This study is designed as a single-center, prospective, single-arm, open-label, exploratory study. The objective is to evaluate the feasibility of Thoracoabdominal Artery Stent Graft System for endovascular treatment of Thoracoabdominal aortic aneurysms (TAAA).
Age: 18 to 80 years old;
Maximum diameter of TAAA is >50 mm;
TAAA diameter increases by more than 5 mm in the past 6 months or by more than 10 mm in the past 1 year;
Definite symptoms associated with TAAA, such as abdominal pain and back pain.
Patients with ruptured thoracoabdominal aortic aneurysms in unstable hemodynamic condition;
Patients with thoracoabdominal aortic dissection;
Patients with infected or mycotic thoracoabdominal aortic aneurysms;
Patients with systemic or local infections that may increase the risk of endovascular graft infection;